Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

Buzz on the Bullboards: The calm before another September rally?

It’s the last leg of what looks like an end-of-month rally as investors try to make the most of August’s losses. Traders are neck-deep into a data-heavy week from company fiscal reports that could chart the hike path for interest rates. ...
Jonathon Brown | August 31, 2023 |

The Golden Question

Call it a dream, stupidity or mere eventuality but a year or two ago when gold was hovering between US$1150/ounce and US$1200/ounce, I spoke about my prediction that gold may hit $2000 US/ounce within a few short years. At this year’s PDAC conference, during...
Dr. Kal Kotecha | September 18, 2019 |

Soliton Shares Rise on Announcement It Will Report Clinical Data at National Dermatology Conference

Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Mee...
Streetwise Reports | October 10, 2019 |

Tax loss selling…is it a good time for investors?

Every year on Black Friday, shoppers anticipate great deals and are lined out the door to get a discount on a TV or on a much needed appliance. Buyers will go to many lengths, including camping outside the store to be the first in or even trampling on other shoppers to get t...
Dr. Kal Kotecha | December 11, 2019 |

Are We There Yet?

Gold is trading around US$1600/ounce. In my interviews that were done between 2017-2019, I was asked about the prospects of gold. I stated that I believed between 2020-2021 we’d see gold above $2000 + ounce. We are getting closer. This bodes extremely well fo...
Dr. Kal Kotecha | February 7, 2020 |

PDAC 2020

PDAC 2020 will be taking place during March 1 st -March 4 th at the Toronto Metro Convention Centre. It is the world’s premier mining and finance conference. “ The World’s Premier Mineral Exploration & Mining Convention is the leading convent...
Dr. Kal Kotecha | February 27, 2020 |

JOIN ME FOR MY TALK AT PDAC 2020

I have the honour of speaking again at PDAC this Sunday March 1st. As you know, it has been a tumultuous week for the overall stock markets including gold stocks. I will be covering that and many other pertinent topics in my talk. I will be speaking at 3:45PM. Following my t...
Dr. Kal Kotecha | February 28, 2020 |

Take a closer look at HelloFresh, Bayer and Altech Advanced Materials

Bayer shares gained around 7 per cent last week. Is this the turnaround after the stock reached a multi-year low? Altech Advanced Materials stock is also working on an upward trend. The German battery hopeful has published a promising feasibility study. Their stationary s...
Fabian Lorenz | April 5, 2024 |

Silver's Sharp Reaction Back

Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. Silver reacted back sharply on Thursday and Friday after a parabolic blowoff top. This was not a final top, but it does indicate that silver needs to take a rest and co...
Streetwise Reports | September 10, 2019 |
1 2 3 4 5 6 7 8 9 10 ...